Literature DB >> 7054631

Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability.

S Koga, N Kaibara, H Kishimoto, H Nishidoi, O Kimura, T Okamoto, H Tamura.   

Abstract

To evaluate whether it is appropriate to estimate the postoperative curability of gastric cancer based on the 5-year survival rate, we compared 5- and 10-year survival rates in 477 primary gastric cancer patients who had undergone gastrectomy during the 8-year period from 1960-1967. In patients who had died more than 5 years after surgery, the cause of death was investigated. The 10-year survival rate of 315 curatively operated patients was 59.1%, 2.9% lower than the 5-year survival rate. Of 176 patients who survived more than 5 years postoperatively, only 9 (5.1%) died of cancer recurrence, suggesting that the 5-year survival rate adequately reflects the curative success of gastric cancer surgery. The postoperative curability of gastric cancer is usually estimated by the 5-year survival rate. However, even in patients who survived for more than 5 years postoperatively, cancer recurrence has been observed. Therefore, we deemed it useful to assess whether it is appropriate to estimate the postoperative curability of gastric cancer based on the 5-year survival rate. From this point of view, we compared the 5- and 10-year survival rates of operated primary gastric patients and investigated the cause of death in patients who died more than 5 years postoperatively. Furthermore, in patients with cancer recurrence more than 5 years postoperatively, the pathologic findings on the cancer in the originally resected specimen were re-evaluated.

Entities:  

Mesh:

Year:  1982        PMID: 7054631     DOI: 10.1007/bf01270600

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  2 in total

1.  The general rules for The gastric cancer study in surgery.

Authors: 
Journal:  Jpn J Surg       Date:  1973-03

2.  Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively.

Authors:  S Koga; H Kishimoto; K Tanaka; H Kawaguchi
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

  2 in total
  2 in total

1.  Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model.

Authors:  Feng Xie; Nan Luo; Hin-Peng Lee
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

2.  Proposed Models for Prediction of Mortality in Stage-I and Stage-II Gastric Cancer and 5 Years after Radical Gastrectomy.

Authors:  Tianyi Fang; Xin Yin; Yufei Wang; Lei Zhang; Xinghai Zhang; Xudong Zhao; Yimin Wang; Yingwei Xue
Journal:  J Oncol       Date:  2022-03-08       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.